1. Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related
death using OpenSAFELY. Nature. 2020; 584: 430–436. 2. Glenn DA, Hegde A, Kotzen E, et …

To the editor: We and others have found a high shortterm seroconversion rate between 71%
and 98% in hemodialysis patients following a complete 2-dose vaccination course with the …

Emerging data has established end-stage renal disease (ESRD) as one of the highest risk
comorbidities for severe coronavirus disease 2019 (COVID-19), with short-term mortality …

The first emergency-use authorizations for COVID-19 vaccines were granted by the Food
and Drug Administration in December 2020, and clinical trials for the approval of more …

Background Patients on hemodialysis have an elevated risk for COVID-19 but were not
included in efficacy trials of SARS-CoV-2 vaccines. Methods We conducted a retrospective …

Background: There is a lack of randomized controlled trial data regarding differences in
immunogenicity of varying COVID-19 mRNA vaccine regimens in chronic kidney disease …

To the editor: We read the excellent series of reports and editorial on the effectiveness of
vaccination in patients on dialysis. 1 We would concur that although vaccination is less …

Background Studies have demonstrated that mRNA-based SARS-CoV-2 vaccines are
highly effective among patients on dialysis. Because individual vaccines may be …

Background Hemodialysis patients are at high risk for severe COVID-19. SARS-CoV-2
vaccination related safety and immunogenicity data in these patients are rare. Methods In …

Background: Differences in immunogenicity between mRNA SARS-CoV-2 vaccines have
not been well characterized in patients undergoing dialysis. We compared the serologic …